Working closely with lawmakers on Capitol Hill and leaders in the Administration, we advocate for policies that promote a stronger addiction treatment workforce, standardize the delivery of individualized addiction treatment, and ensure equitable access and coverage for comprehensive, high-quality addiction care.
-
The office of the Inspector General at HHS released rules which shows they are not expanding the patient engagement and support safe harbor to include cash and cash-equivalent payments offered as part of contingency management interventions or other programs to motivate beneficial behavioral changes.
Full story
-
ASAM sent a letter to congressional leadership opposing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019, which would, among other things, completely remove cannabis from the list of scheduled substances under the Controlled Substances Act (CSA).
Full story
-
ASAM, the Campaign for Tobacco-Free Kids, and 67 partner organizations sent a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn urging him to commence rulemaking to prohibit menthol as a characterizing flavor in cigarettes.
Full story
Subscribe to the ASAM Advocate
Your source for timely, useful news briefings of top stories in addiction policy.